Other 1460 views
Targeted Metabolomics for Biomarker Discovery
Angewandte Chemie International Edition, Volume: 49, Issue: 32, Pages: 5426 - 5445
Swansea University Author: William Griffiths
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1002/anie.200905579
Abstract
Metabolomics is a truly interdisciplinary field of science, which combines analytical chemistry, platform technology, mass spectrometry, and NMR spectroscopy with sophisticated data analysis. Applied to biomarker discovery, it includes aspects of pathobiochemistry, systems biology/medicine, and mole...
Published in: | Angewandte Chemie International Edition |
---|---|
ISSN: | 1433-7851 |
Published: |
2010
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa10764 |
first_indexed |
2013-07-23T12:04:14Z |
---|---|
last_indexed |
2018-02-09T04:39:51Z |
id |
cronfa10764 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2011-10-01T00:00:00.0000000</datestamp><bib-version>v2</bib-version><id>10764</id><entry>2012-05-21</entry><title>Targeted Metabolomics for Biomarker Discovery</title><swanseaauthors><author><sid>3316b1d1b524be1831790933eed1c26e</sid><ORCID>0000-0002-4129-6616</ORCID><firstname>William</firstname><surname>Griffiths</surname><name>William Griffiths</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2012-05-21</date><deptcode>MEDS</deptcode><abstract>Metabolomics is a truly interdisciplinary field of science, which combines analytical chemistry, platform technology, mass spectrometry, and NMR spectroscopy with sophisticated data analysis. Applied to biomarker discovery, it includes aspects of pathobiochemistry, systems biology/medicine, and molecular diagnostics and requires bioinformatics and multivariate statistics. While successfully established in the screening of inborn errors in neonates, metabolomics is now widely used in the characterization and diagnostic research of an ever increasing number of diseases. In this Review we highlight important technical prerequisites as well as recent developments in metabolomics and metabolomics data analysis with special emphasis on their utility in biomarker identification and qualification, as well as targeted metabolomics by employing high-throughput mass spectrometry.</abstract><type>Other</type><journal>Angewandte Chemie International Edition</journal><volume>49</volume><journalNumber>32</journalNumber><paginationStart>5426</paginationStart><paginationEnd>5445</paginationEnd><publisher/><placeOfPublication/><issnPrint>1433-7851</issnPrint><issnElectronic/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2010</publishedYear><publishedDate>2010-12-31</publishedDate><doi>10.1002/anie.200905579</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2011-10-01T00:00:00.0000000</lastEdited><Created>2012-05-21T15:57:39.1735389</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>William J</firstname><surname>Griffiths</surname><order>1</order></author><author><firstname>Therese</firstname><surname>Koal</surname><order>2</order></author><author><firstname>Yuqin</firstname><surname>Wang</surname><order>3</order></author><author><firstname>Matthias</firstname><surname>Kohl</surname><order>4</order></author><author><firstname>David P</firstname><surname>Enot</surname><order>5</order></author><author><firstname>Hans-Peter</firstname><surname>Deigner</surname><order>6</order></author><author><firstname>William</firstname><surname>Griffiths</surname><orcid>0000-0002-4129-6616</orcid><order>7</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
2011-10-01T00:00:00.0000000 v2 10764 2012-05-21 Targeted Metabolomics for Biomarker Discovery 3316b1d1b524be1831790933eed1c26e 0000-0002-4129-6616 William Griffiths William Griffiths true false 2012-05-21 MEDS Metabolomics is a truly interdisciplinary field of science, which combines analytical chemistry, platform technology, mass spectrometry, and NMR spectroscopy with sophisticated data analysis. Applied to biomarker discovery, it includes aspects of pathobiochemistry, systems biology/medicine, and molecular diagnostics and requires bioinformatics and multivariate statistics. While successfully established in the screening of inborn errors in neonates, metabolomics is now widely used in the characterization and diagnostic research of an ever increasing number of diseases. In this Review we highlight important technical prerequisites as well as recent developments in metabolomics and metabolomics data analysis with special emphasis on their utility in biomarker identification and qualification, as well as targeted metabolomics by employing high-throughput mass spectrometry. Other Angewandte Chemie International Edition 49 32 5426 5445 1433-7851 31 12 2010 2010-12-31 10.1002/anie.200905579 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2011-10-01T00:00:00.0000000 2012-05-21T15:57:39.1735389 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine William J Griffiths 1 Therese Koal 2 Yuqin Wang 3 Matthias Kohl 4 David P Enot 5 Hans-Peter Deigner 6 William Griffiths 0000-0002-4129-6616 7 |
title |
Targeted Metabolomics for Biomarker Discovery |
spellingShingle |
Targeted Metabolomics for Biomarker Discovery William Griffiths |
title_short |
Targeted Metabolomics for Biomarker Discovery |
title_full |
Targeted Metabolomics for Biomarker Discovery |
title_fullStr |
Targeted Metabolomics for Biomarker Discovery |
title_full_unstemmed |
Targeted Metabolomics for Biomarker Discovery |
title_sort |
Targeted Metabolomics for Biomarker Discovery |
author_id_str_mv |
3316b1d1b524be1831790933eed1c26e |
author_id_fullname_str_mv |
3316b1d1b524be1831790933eed1c26e_***_William Griffiths |
author |
William Griffiths |
author2 |
William J Griffiths Therese Koal Yuqin Wang Matthias Kohl David P Enot Hans-Peter Deigner William Griffiths |
format |
Other |
container_title |
Angewandte Chemie International Edition |
container_volume |
49 |
container_issue |
32 |
container_start_page |
5426 |
publishDate |
2010 |
institution |
Swansea University |
issn |
1433-7851 |
doi_str_mv |
10.1002/anie.200905579 |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
0 |
active_str |
0 |
description |
Metabolomics is a truly interdisciplinary field of science, which combines analytical chemistry, platform technology, mass spectrometry, and NMR spectroscopy with sophisticated data analysis. Applied to biomarker discovery, it includes aspects of pathobiochemistry, systems biology/medicine, and molecular diagnostics and requires bioinformatics and multivariate statistics. While successfully established in the screening of inborn errors in neonates, metabolomics is now widely used in the characterization and diagnostic research of an ever increasing number of diseases. In this Review we highlight important technical prerequisites as well as recent developments in metabolomics and metabolomics data analysis with special emphasis on their utility in biomarker identification and qualification, as well as targeted metabolomics by employing high-throughput mass spectrometry. |
published_date |
2010-12-31T06:20:39Z |
_version_ |
1822110137282723840 |
score |
11.048302 |